David Masiello

838 total citations
11 papers, 643 citations indexed

About

David Masiello is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, David Masiello has authored 11 papers receiving a total of 643 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 4 papers in Hematology and 3 papers in Molecular Biology. Recurrent topics in David Masiello's work include Chronic Lymphocytic Leukemia Research (3 papers), Estrogen and related hormone effects (3 papers) and Chronic Myeloid Leukemia Treatments (3 papers). David Masiello is often cited by papers focused on Chronic Lymphocytic Leukemia Research (3 papers), Estrogen and related hormone effects (3 papers) and Chronic Myeloid Leukemia Treatments (3 papers). David Masiello collaborates with scholars based in United States and Netherlands. David Masiello's co-authors include Steven P. Balk, Michael L. Lu, Glenn J. Bubley, Allen S. Yang, Suzanne R. Lee, Andrew H. Ko, Kenneth D. Swanson, P A Chatis, Bruce J. Dezube and Katherine Crosby and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

David Masiello

11 papers receiving 626 citations

Peers

Countries citing papers authored by David Masiello

Since Specialization

Citations

This map shows the geographic impact of David Masiello's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Masiello with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Masiello more than expected).

Fields of papers citing papers by David Masiello

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Masiello. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Masiello. The network helps show where David Masiello may publish in the future.

Co-authorship network of co-authors of David Masiello

This figure shows the co-authorship network connecting the top 25 collaborators of David Masiello. A scholar is included among the top collaborators of David Masiello based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Masiello. David Masiello is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	CBP/catenin antagonist safely eliminates drug-resistant leukemia-initiating cells 2015 ·Oncogene ·Yi Zhao, David Masiello, Michael McMillian, Nguyễn Văn Chào, Yongfeng Wu, (unknown), Goar Smbatyan, (unknown), Yi He, (unknown), Michaël Kahn	43
2	The Gamma Catenin/CBP Complex Maintains Survivin Transcription In β-Catenin Deficient/Depleted Cancer Cells. 2010 ·Blood ·Yong‐Mi Kim, Hong Ma, Vivian G. Oehler, (unknown), Cu Nguyen, David Masiello, Han Liu, Yi Zhao, Jerald P. Radich, Michaël Kahn	3
3	Bendamustine therapy in chronic lymphocytic leukemia 2009 ·Expert Opinion on Pharmacotherapy ·David Masiello, Anil Tulpule	2
4	The occurrence and management of fluid retention associated with TKI therapy in CML, with a focus on dasatinib 2009 ·Journal of Hematology & Oncology ·David Masiello, (unknown), Allen S. Yang	49
5	Gender and ethnic differences in chronic myelogenous leukemia prognosis and treatment response: a single-institution retrospective study 2009 ·Journal of Hematology & Oncology ·(unknown), (unknown), David Masiello, Dongyun Yang, Allen S. Yang	18
6	Hemoglobin SE disease—A concise review 2007 ·American Journal of Hematology ·David Masiello, Matthew M. Heeney, Adeboye H. Adewoye, (unknown), Hongyuan Luo, Martin H. Steinberg, David H.K. Chui	28
7	Combining an mTOR antagonist and receptor tyrosine kinase inhibitors for the treatment of prostate cancer 2007 ·Cancer Biology & Therapy ·David Masiello, M. Golam Mohi, Nicole C. McKnight, Bradley L. Smith, (unknown), (unknown), Glenn J. Bubley	20
8	Imatinib-Induced Regression of AIDS-Related Kaposi's Sarcoma 2004 ·Journal of Clinical Oncology ·Henry Koon, Glenn J. Bubley, Liron Pantanowitz, David Masiello, Brad Smith, Katherine Crosby, (unknown), (unknown), Thomas E. Miller, P A Chatis, Merrill J. Egorin, Steven R. Tahan, Bruce J. Dezube	115
9	Recruitment of β-Catenin by Wild-Type or Mutant Androgen Receptors Correlates with Ligand-Stimulated Growth of Prostate Cancer Cells 2004 ·Molecular Endocrinology ·David Masiello, Shaoyong Chen, Youyuan Xu, Manon C. Verhoeven, (unknown), Anthony N. Hollenberg, Steven P. Balk	58
10	Bicalutamide Functions as an Androgen Receptor Antagonist by Assembly of a Transcriptionally Inactive Receptor 2002 ·Journal of Biological Chemistry ·David Masiello, (unknown), Glenn J. Bubley, Michael L. Lu, Steven P. Balk	193
11	AR and ER Interaction with a p21-Activated Kinase (PAK6) 2002 ·Molecular Endocrinology ·Suzanne R. Lee, (unknown), Andrew H. Ko, David Masiello, Kenneth D. Swanson, Michael L. Lu, Steven P. Balk	114

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact